Joel Linden

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Immune Response

Top Venues

Science advances

Cancer research

Cancer immunology research

University of California San Diego

University of Virginia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Diego

United States

Adjunct Professor :: Pharmacology

La Jolla Institute for Allergy and Immunology

United States

Professor :: Developmental Immunology

Education History

University of Virginia

United States

PHD :: Pharmacology

Brown University

United States

BSC :: Applied Mathematics and Biology

Publications

Lin Wang, Luz M Londono, Jessica Cowell, Ozge Saatci, Mertkaya Aras, Pelin G Ersan, Sara Serra, Hong Pei, Renee Clift, Qiping Zhao, Kim B Phan, Lei Huang, Michael J LaBarre, Xiaoming Li, H Michael Shepard, Silvia Deaglio, Joel Linden, Christopher D Thanos, Özgür Sahin, Caglar Cekic
Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors. Cancer research 81 (12) (2021)
Rekha Dhanwani, Mariko Takahashi, Ian T Mathews, Camille Lenzi, Artem Romanov, Jeramie D Watrous, Bartijn Pieters, Catherine C Hedrick, Chris A Benedict, Joel Linden, Roland Nilsson, Mohit Jain, Sonia Sharma
Cellular sensing of extracellular purine nucleosides triggers an innate IFN-β response. Science advances 6 (30) (2020)
Siqi Chen, Imran Akdemir, Jie Fan, Joel Linden, Bin Zhang, Caglar Cekic
The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth. Cancer immunology research 8 (8) (2020)